Lynparza

Indicated For

ovarian cancer, breast cancer, prostate cancer, pancreatic cancer

About This Medication

# AstraZeneca Patient Assistance Program for Lynparza (olaparib) Patient Guide: How to Get Lynparza at Low or No Cost Lynparza (olaparib) is a prescription medication used to treat certain types of cancers, including ovarian, breast, pancreatic, and prostate cancers with specific genetic mutations like BRCA1 or BRCA2. It's a type of targeted therapy called a PARP inhibitor that helps stop cancer cells from growing and spreading. If you're facing high costs for Lynparza, AstraZeneca's patient assistance program (often called the AstraZeneca Patient Assistance Program or AZ&Me Prescription Savings Program) can help eligible patients get it for free or at a very low cost. This guide explains everything you need to know in simple terms. ## Who Qualifies for the Program? The AstraZeneca program is designed for patients who are uninsured or underinsured and meet specific financial criteria. Generally, you qualify if: - You live in the United States (including Puerto Rico and other U.S. territories). - You have a valid prescription for Lynparza from a U.S. licensed doctor. - Your household income is at or below **400% of the Federal Poverty Level (FPL)**. This is the most common threshold, though it can vary slightly by program specifics. - You are 18 years or older (or have a legal guardian apply). - You are not enrolled in government programs like Medicaid in most cases, though some exceptions apply for Medicare patients without supplemental coverage. **Important:** AstraZeneca also offers a co-pay savings card for commercially insured patients, which can reduce out-of-pocket costs to as low as $0 for eligible individuals. This guide focuses on the full patient assistance program for those without adequate insurance. ## About Lynparza (Olaparib) Lynparza is an oral tablet taken twice daily, with or without food. It's FDA-approved for maintenance treatment after chemotherapy in certain advanced cancers and for first-line treatment in combination with other therapies. Common side effects include nausea, fatigue, anemia, vomiting, diarrhea, and low blood cell counts. Always take it as prescribed and report side effects to your doctor. Do not stop or adjust your dose without medical advice. For full details, refer to the patient information leaflet or consult your healthcare provider. ## Income Eligibility Breakdown Eligibility is based on your total household income before taxes, including wages, Social Security, pensions, and other sources. Household size includes you, your spouse, and dependents. The table below shows approximate 2026 Federal Poverty Level (FPL) thresholds at **400% FPL**, AstraZeneca's standard cutoff. These update annually; check the official site for exact figures. | Household Size | Annual Income Limit (400% FPL) | |---------------|-------------------------------| | 1 (Individual) | $60,320 | | 2 (Couple) | $81,760 | | 3 | $103,200 | | 4 | $124,640 | | 5 | $146,080 | | 6 | $167,520 | | +1 per additional | +$21,440 | **Notes:** Income limits may be higher (up to 700-800% FPL) for rare disease programs or Medicare patients. Expenses like high medical costs can sometimes be deducted. Provide proof like tax returns or pay stubs. ## Insurance Requirements - **Uninsured patients:** Fully eligible if income-qualified. - **Underinsured (e.g., high deductibles):** May qualify if insurance doesn't cover Lynparza fully. - **Medicare Part D:** Eligible if you don't receive Extra Help and meet income criteria. The program can cover gaps. - **Medicaid:** Generally ineligible, as government programs take priority. - **Commercial insurance:** Use the separate Lynparza Savings Card first (up to $25,000/year savings), then apply for assistance if needed. AstraZeneca requires proof of insurance status. If denied by insurance, submit the denial letter. ## Step-by-Step Application Process 1. **Talk to your doctor:** Confirm Lynparza is right for you and get a prescription. Ask them to complete the application (they sign Section 2). 2. **Gather documents:** - Proof of income (e.g., last 2 pay stubs, 2025 tax return, W-2s, SSI award letter). - Proof of residency (utility bill, lease). - Insurance card or denial letter. - Photo ID. 3. **Apply online, by phone, or mail:** - **Online:** Visit www.AZandMeApp.com or www.Lynparza.com/savings-support (fastest). - **Phone:** Call 1-800-AZandMe (1-800-292-6363), Mon-Fri 9AM-8PM ET. - **Download form:** Print from AstraZeneca site, fill out, and mail to PO Box 220965, Charlotte, NC 28222. 4. **Submit:** Doctor faxes signed form to 1-800-297-6615 or uploads online. Patient submits household/financial sections. 5. **Track status:** Use the phone number or online portal. ## Timeline and Delivery - **Processing time:** 2-4 weeks after complete application received. Urgent cases may be expedited (call to request). - **Approval notification:** Mailed or emailed; check spam. - **Delivery:** Free medication shipped to your doctor's office or home via specialty pharmacy (e.g., Accredo or AllianceRx). First shipment often within 7-10 days of approval. - **Supply duration:** Up to 90-day supply per shipment. ## Alternatives if Denied - **Appeal:** Submit additional documents or updated income proof within 30 days. - **Co-pay card:** For insured patients, get at www.LynparzaSavings.com (eligible up to $25,000/year). - **Other programs:** PAN Foundation, Patient Access Network (income up to 500% FPL), or HealthWell Foundation grants. - **Generic olaparib:** No FDA-approved generic as of 2026; biosimilars unlikely soon. - **State programs:** Check your state's pharmaceutical assistance. - **Manufacturer bridge program:** Temporary supply while appealing. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Program details can change; always verify with AstraZeneca at 1-800-AZandMe or their website. Not medical advice—consult your doctor for treatment decisions. AstraZeneca reserves the right to modify eligibility or discontinue the program. Word count: 1028.

Program information last verified: March 25, 2026